Comparison

Galunisertib European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 100mg
Item no. TMO-T2510-100mg
CASRN 700874-72-2
eClass 6.1 32169090
eClass 9.0 32169090
Available
Alias TGF-beta/Smad inhibitor, LY2157299
Short Description
Galunisertib is an orally available inhibitor of TGFβRI kinase (IC50: 56 nM) with potential antineoplastic activity.
Shipping
cool pack
Storage
-20°
Target names or alias
LY2157299
Molecular Weight
369, 42
Pathway
Stem Cells
Target
TGF-beta/Smad

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close